Paige Twenter

Omicron, a COVID-19 strain first discovered in 2021, has mutated dozens of times and now dominates global virus strains. As it reaches its two-year anniversary, virologists are reckoning with a virus mutation that isn't following a normal path.

Exela Pharma Sciences, an injectable drug company, is recalling more than 415,000 drug vials in a Class I recall because of a possible presence of silicone, according to the FDA.

Eli Lilly's Mounjaro helped patients lose weight more effectively than Novo Nordisk's Ozempic, according to a preprint study that included more than 40,000 patients.

The Wisconsin pharmacy board is investigating a hospital pharmacist's license after a federal court charged him for animal cruelty related to research, ABC affiliate WKOW 27 reported Nov. 22.

A CDC-recommended hospital disinfectant is ineffective against Clostridioides difficile , according to a study published Nov. 21 in Microbiology

Genesis Medical Center-Dewitt, a MercyOne-owned hospital in Iowa, bought a local pharmacy to include in its network, Our Quad Cities reported Nov. 27.

The prevalence of COVID-19 omicron strain BA.2.86 has more than tripled globally in four weeks, prompting the World Health Organization to name it a variant of concern.

The FDA approved Ogsiveo, the first drug indicated for locally aggressive, noncancerous tumors, to treat a rare subtype of soft tissue sarcomas.

Novartis recalled two lots of its organ rejection drug Sandimmune because crystallization was discovered in some bottles, the FDA said Nov. 27.

Unomedical A/S, a maker of single-use medical devices, is pulling about 130,000 insulin infusion products from the market because it might detach mid-infusion, according to the FDA